Skip to content
PeptideAgent

Are peptides legal in Colorado?

By the PeptideAgent Editorial Team. Draft, pending editorial review.  Last verified

The short answer

Yes. A Colorado resident can obtain FDA approved peptides such as semaglutide and tirzepatide by prescription from a Colorado-licensed provider, including by telehealth, because Colorado law treats telehealth as the practice of medicine where the patient is located (C.R.S. 12-240-107) and the Colorado Medical Board allows a provider-patient relationship to be formed through telehealth under its telehealth policies. Compounded peptides are available when eligible under federal 503A rules and dispensed by a Colorado prescription drug outlet or a nonresident prescription drug outlet registered with the Colorado State Board of Pharmacy under C.R.S. 12-280-133, which must supply a recent inspection report from its home-state board or a national pharmacy verification program and may ship compounded drugs into Colorado only on patient-specific prescriptions.

Regulatory: Telehealth allowedRegulatory: Async allowedRegulatory: Compounded GLP-1 limitedVerified: Verified Sep 22, 2026
Compounding rules
Follows the federal 503A framework
Telehealth prescribing
Allowed, asynchronous allowed
Compounded GLP-1
Limited

Can a Colorado resident get peptides by telehealth?

C.R.S. 12-240-107 includes telemedicine in the definition of the practice of medicine, and the practice occurs where the patient is located, so the prescriber needs a Colorado license (Colorado participates in the Interstate Medical Licensure Compact, which is one route to that license). The Colorado Medical Board's published policies (Policy 40-03 on the provider-patient relationship, revised 2015, and Policy 40-27, guidelines for the appropriate use of telehealth technologies, issued 2015 and revised December 18, 2020 and August 19, 2021) say a provider-patient relationship may be established through telehealth whether or not there has been an in-person encounter, as long as it conforms to generally accepted standards of practice, the provider verifies the patient's identity and location, discloses the provider's identity and credentials, and obtains appropriate informed consent. Policy 40-27 defines telehealth to include store-and-forward transfers, requires an appropriate medical evaluation and review of relevant clinical history before any prescription, holds online prescribing to in-person standards, and states that treatment, including a prescription, based solely on an online questionnaire does not constitute an acceptable standard of care. The policies do not require a real-time video visit, so a first non-controlled prescription may follow an asynchronous evaluation that meets that standard, but a questionnaire-only intake does not. [2] [3] [4] [16]

How does the Colorado pharmacy board treat compounding?

Compounding regulator for Colorado
BoardColorado State Board of Pharmacy (Division of Professions and Occupations)
Eligible substancesFollows the federal 503A framework

The Colorado State Board of Pharmacy regulates compounding under the Pharmacy Practice Act (C.R.S. Title 12, Article 280, including section 12-280-120 on compounding and dispensing) and Board rules at 3 CCR 719-1. Colorado has no separate state bulks list, so peptide eligibility follows the federal 503A framework (approved drug component, USP or NF monograph, or FDA 503A bulks list). Under C.R.S. 12-280-133, a prescription drug outlet outside Colorado that ships, mails, or delivers drugs into Colorado is a nonresident prescription drug outlet and must register with the Board, disclose its officers and the pharmacists dispensing to Colorado residents, keep its home-state license valid, and submit its most recent home-state inspection report. Board Rule 5.00.15 accepts an inspection by the home-state board or by a national pharmacy verification program dated within the previous two years and requires an affidavit that the outlet will not ship drugs into Colorado without a patient-specific prescription; an annual third-party inspection is required only for the separate case of distributing compounded products to Colorado veterinarians (Rule 21.00.20). Compounding standards are in Rule 21.00.00 of 3 CCR 719-1, and Rule 21.20.00 (Compounding of Sterile Products) with Rules 21.21.00 and 21.22.00 governs sterile preparations such as injectable peptides. The Board has a permanent rulemaking hearing set for October 1, 2026 on proposed revisions to its compounding rules to align them with recent FDA guidance. [1] [5] [7] [9] [10]

Can you get compounded GLP-1s in Colorado?

Regulatory: Compounded GLP-1 limited

Colorado patients using a telehealth GLP-1 program should confirm the prescriber holds a Colorado license and that an out-of-state dispensing pharmacy appears as a registered nonresident prescription drug outlet. The Board of Pharmacy rules (3 CCR 719-1) contain no GLP-1-specific provision, and a 2026 bill to regulate the marketing and distribution of compounded GLP-1 weight-loss medication (SB26-066) was postponed indefinitely in a House committee on May 5, 2026 and did not become law, so federal compounding limits and the general Colorado rules apply. [5] [7] [8] [13] [14]

Prices by channel: semaglutide cost, tirzepatide cost.

Approvals, shortage history, and prices for every GLP-1 we track are on the GLP-1 hub.

What is the legal access path in Colorado?

Verified access options

Access paths are verified against public regulatory records and prescriber licensing. We never list unlicensed vendors.

Find a provider in Colorado

Is it legal to buy research peptides in Colorado?

Only registered prescription drug outlets, including registered nonresident outlets, may dispense prescription drugs to Colorado patients. "Research use only" peptides sold for human injection are unapproved new drugs under federal law regardless of labeling and are not dispensed by a pharmacist. Colorado law also bars the sale directly: C.R.S. 12-280-131 says no person shall sell, deliver, offer for sale, hold for sale, or give away any new drug not authorized to move in interstate commerce under federal law, with an exception only for drugs intended solely for investigational use by qualified experts and plainly labeled for investigational use only. [5] [6] [15]

Peptide-specific notes for Colorado

Peptide-specific notes for Colorado
PeptideNote
SemaglutideAvailable branded by prescription, including by telehealth from a Colorado-licensed provider under the Medical Board's telehealth policies. Compounded semaglutide is limited to documented patient-specific needs since the 503A grace period ended April 22, 2025. [3] [13]

Frequently asked questions

Can a telehealth provider prescribe me a GLP-1 in Colorado without an in-person visit?

Yes, if the provider holds a Colorado license and establishes a provider-patient relationship that meets generally accepted standards of practice. Colorado treats telemedicine as practicing medicine where the patient is located, and the Colorado Medical Board's telehealth policies allow the relationship to be formed through telehealth with appropriate informed consent. [3] [4]

What does an out-of-state pharmacy need to ship compounded peptides to Colorado?

Registration as a nonresident prescription drug outlet with the Colorado State Board of Pharmacy under C.R.S. 12-280-133. The outlet must submit a recent inspection report from its home-state board or a national pharmacy verification program, keep its home-state license valid, and ship compounded drugs into Colorado only on patient-specific prescriptions, so check the Division of Professions and Occupations license lookup before ordering. [1] [5] [7]

What Colorado-specific rules apply to GLP-1 programs?

Colorado patients using a telehealth GLP-1 program should confirm the prescriber holds a Colorado license and that an out-of-state dispensing pharmacy appears as a registered nonresident prescription drug outlet. Colorado has no GLP-1-specific pharmacy rule; a 2026 bill aimed at compounded GLP-1 weight-loss medication (SB26-066) did not become law. [5] [8] [13] [14]

Can a Colorado pharmacy compound BPC-157?

No, not from bulk today. BPC-157 is not on the 503A bulks list. PCAC's July 2026 recommendation is advisory, and until FDA publishes a final rule a 503A pharmacy has no federal basis to compound it from bulk. State boards cannot authorize what federal law does not. Peptides still in FDA Category 2 cannot be compounded either. [9] [11] [12]

Sources

Numbered citations above point to these primary sources: the state statute or rule, the pharmacy board, and federal FDA guidance.

  1. [1]Colorado State Board of Pharmacy, Division of Professions and Occupations
  2. [2]Colorado Medical Board, Division of Professions and Occupations
  3. [3]Colorado Medical Board Policies (Policy 40-03 provider-patient relationship; Policy 40-27 telehealth guidelines, revised August 19, 2021), linked from the Board homepage, accessed 2026-09-22
  4. [4]C.R.S. 12-240-107, Practice of medicine defined (includes telemedicine)
  5. [5]C.R.S. 12-280-133, Nonresident prescription drug outlet, registration, accessed 2026-09-22
  6. [6]C.R.S. 12-280-131, New drugs, when sales permissible, accessed 2026-09-22
  7. [7]Colorado Secretary of State, Code of Colorado Regulations 3 CCR 719-1, State Board of Pharmacy Rules (current version effective August 21, 2026; Rules 5.00.15, 21.00.00, 21.20.00), accessed 2026-09-22
  8. [8]Colorado General Assembly: SB26-066, Regulation of Compounded Weight-Loss Medication (postponed indefinitely May 5, 2026), accessed 2026-09-22
  9. [9]C.R.S. 12-280-120, Compounding, dispensing, and sale of drugs and devices
  10. [10]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA

Cite this page

Free to cite and quote with a link. Data is licensed CC BY 4.0 with attribution to PeptideAgent.

APA style
PeptideAgent. (2026, September 22). Are peptides legal in Colorado?. https://peptideagent.ai/legal/colorado
HTML link
<a href="https://peptideagent.ai/legal/colorado">Are peptides legal in Colorado?</a>, PeptideAgent, updated September 22, 2026.